Interim 18-FDG-Positron Emission Tomography/Computed Tomography (PET) Failed to Predict Different Outcome in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab-CHOP.Patrizia Pregno, Umberto Vitolo, Annalisa Chiappella et al.|Blood|2009Cited by 12
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyureaFrancesca Palandri, Valerio De Stefano, Giulia Benevolo et al.|Leukemia|2025Cited by 6